NATRIURETIC PEPTIDES AND ADIPONECTIN IN SUBJECTS WITH A METABOLIC SYNDROME
摘要
<p>The present invention is concerned with a method for predicting the risk of mortality and/or a cardiovascular event in a subject who suffers from the metabolic syndrome based on the determination of a natriuretic peptide and adiponectin in a sample of a subject. Moreover, the present invention relates to a method for identifying a subject being susceptible to a therapy that intends to increase the level of adiponectin in a subject based on the determination of the aforementioned markers. Further comprised by the present invention are kits and devices adapted to carry out the method of the present invention.</p>
申请公布号
WO2010029116(A1)
申请公布日期
2010.03.18
申请号
WO2009EP61723
申请日期
2009.09.10
申请人
F. HOFFMANN-LA ROCHE AG;ROCHE DIAGNOSTICS GMBH;HESS, GEORG;HORSCH, ANDREA;ZDUNEK, DIETMAR